Steroid receptor/coactivator binding inhibitors: An update

Mol Cell Endocrinol. 2019 Aug 1:493:110471. doi: 10.1016/j.mce.2019.110471. Epub 2019 Jun 1.

Abstract

The purpose of this review is to highlight recent developments in small molecules and peptides that block the binding of coactivators to steroid receptors. These coactivator binding inhibitors bind at the coregulator binding groove, also known as Activation Function-2, rather than at the ligand-binding site of steroid receptors. Steroid receptors that have been targeted with coactivator binding inhibitors include the androgen receptor, estrogen receptor and progesterone receptor. Coactivator binding inhibitors may be useful in some cases of resistance to currently prescribed therapeutics. The scope of the review includes small-molecule and peptide coactivator binding inhibitors for steroid receptors, with a particular focus on recent compounds that have been assayed in cell-based models.

Keywords: Androgen receptor; Coactivator binding inhibitors; Estrogen receptor; Progesterone receptor; Protein-protein interactions; Steroid receptor coactivator.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Binding Sites / drug effects
  • Humans
  • Models, Molecular
  • Peptides / chemistry
  • Peptides / pharmacology*
  • Protein Binding / drug effects
  • Protein Conformation
  • Receptors, Androgen / chemistry
  • Receptors, Androgen / metabolism
  • Receptors, Estrogen / chemistry
  • Receptors, Estrogen / metabolism
  • Receptors, Progesterone / chemistry
  • Receptors, Progesterone / metabolism
  • Receptors, Steroid / chemistry
  • Receptors, Steroid / metabolism*
  • Small Molecule Libraries / chemistry
  • Small Molecule Libraries / pharmacology*

Substances

  • Peptides
  • Receptors, Androgen
  • Receptors, Estrogen
  • Receptors, Progesterone
  • Receptors, Steroid
  • Small Molecule Libraries